Insider Trading History of Aguiar Eric

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Aguiar Eric since year 2005. The trader's CIK number is 1262325. At the time of the last reporting, Aguiar Eric was the Director of Eidos Therapeutics, Inc. . (stock ticker symbol EIDX). See this page for all insider trading activities at Eidos Therapeutics, Inc. .

Note that in the past AGUIAR ERIC also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Aguiar Eric since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-07-03 EIDX Eidos Therapeutics, Inc. Buy 882,353 29.90 26,383,237
2019-05-24 EIDX Eidos Therapeutics, Inc. Buy 1,103,848 25.93 28,622,778
2019-02-04 BHVN Biohaven Pharmaceutical Holding Co Ltd. Option Ex 35,218 29.61 1,042,910
2018-11-27 NVTA Invitae Corp Sale 10,000 13.50 135,000
2016-11-18 NVTA Invitae Corp Buy 10,000 6.28 62,830
2007-08-03 HAQ Altimmune, Inc. Buy 125,000 7.66 957,500
2007-08-03 HAQ Activbiotics Inc Buy 125,000 7.66 957,500
2007-04-12 AVNC Advancis Pharmaceutical Corp Buy 682,903 2.36 1,613,699

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aguiar Eric (Director of Eidos Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.